# Prelude Therapeutics Inc: Form SC 13D/A, filed May 24, 2023

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: SC 13D/A
- Filed: 2023-05-24
- Accepted by EDGAR: May 24, 2023, 16:31 ET
- Period: not reported
- Accession: 0001104659-23-064148
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000110465923064148/tm2316505d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000110465923064148/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000110465923064148/tm2316505d1_sc13da.htm

Filed May 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-064148. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
